XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
0.8765
-0.0017 (-0.19%)
Oct 14, 2025, 10:33 AM EDT - Market open

XORTX Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Jan '22 Dec '20 2015 - 2019
54412269
Upgrade
Market Cap Growth
-1.73%-6.84%-63.14%-53.60%177.78%19.02%
Upgrade
Enterprise Value
42-13229
Upgrade
Last Close Price
0.881.132.317.2718.4512.26
Upgrade
PB Ratio
2.291.230.951.701.949.37
Upgrade
P/TBV Ratio
2.541.300.981.751.9711.52
Upgrade
Debt / Equity Ratio
0.040.010.000.01--
Upgrade
Quick Ratio
1.513.294.256.9626.970.18
Upgrade
Current Ratio
1.783.534.937.2128.781.99
Upgrade
Return on Equity (ROE)
-79.44%-83.06%-37.08%-76.43%-22.25%-245.97%
Upgrade
Return on Assets (ROA)
-42.16%-34.21%-34.72%-38.82%-15.04%-40.80%
Upgrade
Return on Capital (ROIC)
-64.89%-40.74%-52.83%-56.97%-20.34%-125.84%
Upgrade
Earnings Yield
-40.41%-81.03%-49.17%-64.82%-6.15%-10.91%
Upgrade
FCF Yield
-66.08%-89.96%-150.08%-68.74%-18.71%-6.19%
Upgrade
Buyback Yield / Dilution
-46.89%-45.25%-33.91%-35.25%-47.77%-24.34%
Upgrade
Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q